Sales & Marketing
Why trust is becoming pharma’s most important visibility met...
Any gap between an AI-generated answer and a product’s approved profile carries consequences for prescribing decisions and patient safety.
R&D
CAMP4 on a new class of ASO in gene under expression
CAMP4 Therapeutics CFO Kelly Gold discusses developments in antisense oligonucleotides and CAMP4’s CMP-002 study
Patients
Progress with England’s Single National Formulary after a ye...
Leela Barham digs deeper into the progress update from NHS England in July 2026.
R&D
Drug discovery has a human biology problem
The current opportunity lies in optimising existing discovery methodologies by generating more predictive, reproducible human data.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
